Back
Ovintiv Vs. Viking Therapeutics Industry Stock Comparison
Sell
41
OVV
Ovintiv
Last Price:
46.87
Seasonality Move:
-0.52%
Sell
47
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
Sell
41
Ovintiv (OVV)
is a Sell
Is Ovintiv a Buy, Sell or Hold?
- The current Ovintiv [OVV] share price is $46.87. The Score for OVV is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- OVV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $52.96. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OVV Stock Price Chart
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $52.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
OVV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.86 | Sell |
| Relative Strength Index (14 RSI): | 44.93 | Sell |
| Chaikin Money Flow: | -3193925 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.23 - 49.13) | Sell |
| Bollinger Bands (100): | (46.07 - 52.71) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.9 | Sell |
| Relative Strength Index (14 RSI): | 43.41 | Sell |
| Chaikin Money Flow: | 113403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.34 - 60.74) | Sell |
| Bollinger Bands (100): | (47.23 - 79.29) | Sell |
OVV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.49 | Buy |
| 20-day SMA: | 47.34 | Sell |
| 50-day SMA: | 49.43 | Sell |
| 200-day SMA: | 47.19 | Sell |
| 8-day EMA: | 46.64 | Buy |
| 20-day EMA: | 47.31 | Sell |
| 50-day EMA: | 48.57 | Sell |
| 200-day EMA: | 47.37 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.6 | Buy |
| 20-day SMA: | 53.66 | Sell |
| 50-day SMA: | 63.66 | Sell |
| 200-day SMA: | 39.18 | Buy |
| 8-day EMA: | 51.13 | Buy |
| 20-day EMA: | 54.21 | Sell |
| 50-day EMA: | 59.37 | Sell |
| 200-day EMA: | 45.7 | Buy |
Ovintiv Earnings Growth & OVV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.32 per share, and an increase next year of $1.13 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Ovintiv Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||